Under NYSE rules, Crescent Point can regain compliance at any time during the granted cure period ending December 29, 2020, by having a closing share price and a 30 trading-day average closing share price of at least US$1.00 on the last trading day of any calendar month. Failure to regain compliance could lead to delisting. The Company’s shares will continue to be listed and traded on the NYSE during the cure period subject to compliance with other continued listing requirements. The NYSE will assign a “.BC” suffix to the Company symbol “CPG” throughout the cure period representing Crescent Point as below compliance of the NYSE price listing standard.
This notice does not impact Crescent Point’s ongoing business operations, its reporting requirements to the U.S. Securities and Exchange Commission or the continued listing and trading of the Company’s common shares on the Toronto Stock Exchange. The notification is not discretionary and is sent by the NYSE when a listed company’s share price falls below the continued listing standard requirement.
FOR MORE INFORMATION ON CRESCENT POINT ENERGY, PLEASE CONTACT:
Brad Borggard, Senior Vice President, Corporate Planning and Capital Markets, or
Shant Madian, Vice President, Investor Relations and Corporate Communications
Telephone: (403) 693-0020 Toll-free (US and Canada): 888-693-0020 Fax: (403) 693-0070
Address: Crescent Point Energy Corp. Suite 2000, 585 – 8th Avenue S.W. Calgary AB T2P 1G1
Crescent Point shares are traded on the Toronto Stock Exchange and New York Stock Exchange under the symbol CPG.
